Regulatory Approval of Cancer Risk-reducing (Chemopreventive) Drugs: Moving What We Have Learned into the Clinic

This paper endeavors to clarify the current requirements and status of regulatory approval for chemoprevention (risk reduction) drugs and discusses possible improvements to the regulatory pathway for chemoprevention. Covering a wide range of topics in as much depth as space allows, this report is wr...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Meyskens, Frank L., Curt, Gregory A., Brenner, Dean E., Gordon, Gary, Herberman, Ronald B., Finn, Olivera, Kelloff, Gary J., Khleif, Samir N., Sigman, Caroline C., Szabo, Eva
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2011
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3059243/
https://ncbi.nlm.nih.gov/pubmed/21372031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-09-0014
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk